Search research articles
Contact Us
Filters
Showing results (81-90 of 97) with videos related to
Page
of 10
Sort By:
NPJ Parkinson'S Disease
|
March 25, 2023
DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson's disease
Anna Masato, Nicoletta Plotegher, Francesca Terrin, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
October 27, 2010
Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice
Richard A Miller, David E Harrison, C M Astle, et al.
Aging Cell
|
January 29, 2019
Acarbose improves health and lifespan in aging HET3 mice
David E Harrison, Randy Strong, Silvestre Alavez, et al.
Aging Cell
|
March 31, 2021
17-a-estradiol late in life extends lifespan in aging UM-HET3 male mice; nicotinamide riboside and three other drugs do not affect lifespan in either sex
David E Harrison, Randy Strong, Peter Reifsnyder, et al.
Nature
|
May 27, 2026
Universal transcriptomic hallmarks of mammalian ageing and mortality
Alexander Tyshkovskiy, Daria Kholdina, Maria Davitadze, et al.
Geroscience
|
May 16, 2024
Lifespan effects in male UM-HET3 mice treated with sodium thiosulfate, 16-hydroxyestriol, and late-start canagliflozin
Richard A Miller, David E Harrison, Gino A Cortopassi, et al.
Geroscience
|
June 19, 2025
Correction to: Lifespan effects in male UM‑HET3 mice treated with sodium thiosulfate, 16-hydroxyestradiol, and late‑start canagliflozin
Richard A Miller, David E Harrison, Gino A Cortopassi, et al.
JCI Insight
|
September 29, 2020
Canagliflozin extends life span in genetically heterogeneous male but not female mice
Richard A Miller, David E Harrison, David B Allison, et al.
Geroscience
|
July 14, 2024
Correction to: Lifespan effects in male UM‑HET3 mice treated with sodium thiosulfate, 16‑hydroxyestriol, and late‑start canagliflozin
Richard A Miller, David E Harrison, Gino A Cortopassi, et al.
Geroscience
|
March 17, 2026
Astaxanthin, meclizine, mitoglitazone, pioglitazone, alpha-ketoglutarate, mifepristone, methotrexate, and atorvastatin-telmisartan do not increase lifespan in UM-HET3 mice
Ron Korstanje, Randy Strong, Adam B Salmon, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 97) with videos related to
Sort By:
Page
of 10
NPJ Parkinson'S Disease
|
March 25, 2023
DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson's disease
Anna Masato, Nicoletta Plotegher, Francesca Terrin, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
October 27, 2010
Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice
Richard A Miller, David E Harrison, C M Astle, et al.
Aging Cell
|
January 29, 2019
Acarbose improves health and lifespan in aging HET3 mice
David E Harrison, Randy Strong, Silvestre Alavez, et al.
Aging Cell
|
March 31, 2021
17-a-estradiol late in life extends lifespan in aging UM-HET3 male mice; nicotinamide riboside and three other drugs do not affect lifespan in either sex
David E Harrison, Randy Strong, Peter Reifsnyder, et al.
Nature
|
May 27, 2026
Universal transcriptomic hallmarks of mammalian ageing and mortality
Alexander Tyshkovskiy, Daria Kholdina, Maria Davitadze, et al.
Geroscience
|
May 16, 2024
Lifespan effects in male UM-HET3 mice treated with sodium thiosulfate, 16-hydroxyestriol, and late-start canagliflozin
Richard A Miller, David E Harrison, Gino A Cortopassi, et al.
Geroscience
|
June 19, 2025
Correction to: Lifespan effects in male UM‑HET3 mice treated with sodium thiosulfate, 16-hydroxyestradiol, and late‑start canagliflozin
Richard A Miller, David E Harrison, Gino A Cortopassi, et al.
JCI Insight
|
September 29, 2020
Canagliflozin extends life span in genetically heterogeneous male but not female mice
Richard A Miller, David E Harrison, David B Allison, et al.
Geroscience
|
July 14, 2024
Correction to: Lifespan effects in male UM‑HET3 mice treated with sodium thiosulfate, 16‑hydroxyestriol, and late‑start canagliflozin
Richard A Miller, David E Harrison, Gino A Cortopassi, et al.
Geroscience
|
March 17, 2026
Astaxanthin, meclizine, mitoglitazone, pioglitazone, alpha-ketoglutarate, mifepristone, methotrexate, and atorvastatin-telmisartan do not increase lifespan in UM-HET3 mice
Ron Korstanje, Randy Strong, Adam B Salmon, et al.
Page
of 10